BioSpace News Archive

Dyne Therapeutics, Inc today announced that management is scheduled to present at the following investor conferences in November.

QuantuMDx Group Limited and A.Menarini Diagnostics S.r.I., are pleased to announce an exclusive distribution agreement for QuantuMDx’s Q-POC™ platform in the UK and France.

Inspire Medical Systems, Inc. announced that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at three upcoming investor conferences.

Tempest Therapeutics, Inc. (Nasdaq: TPST) today announced the acceptance of two poster presentations, including a late-breaking presentation on the company’s oral selective PPAR⍺ antagonist, TPST-1120, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting taking place November 10-12, 2022 in Boston, MA.